{
  "figure_1": "a UMAP representation 7930 cells, profiled with single cell RNA-seq from 28 glioblastomas in Ref. 15. Malignant cells are highlighted. Cells from adult and pediatric glioblastomas, 5742 and 2188 respectively, are color-coded. b Distributions of PROM1 expression in adult and pediatric glioblastoma malignant cells (n = 4916 adult malignant cells; n = 1947 pediatric malignant cells). Differences in the distributions were tested with two-tailed Wilcoxon rank-sum test. c UMAP representation of glioblastoma malignant cells, color-coded according to PROM1 expression. d UMAP representation of cycling and non-cycling glioblastoma malignant cells (3671 and 3192, respectively). e Percentage of non-cycling PROM1+ cells among malignant cells of adult and pediatric glioblastomas. Pediatric non-cycling PROM1+ cells were further classified according to the expression of SOX2 and OLIG2 into four subpopulations. f Schematic representations of the comparisons performed to characterize specific subpopulations of malignant cells from pediatric glioblastomas: among non-cycling cells, 313 PROM1+ cells were compared to 548 PROM1- cells (PROM1+ vs PROM1-). Among PROM1+ cells, 313 non-cycling and 523 cycling cells were compared (non-cycling vs cycling). g Number of marker genes identified by comparing non-cycling PROM1+ vs PROM1- cells (top bar) and cycling vs non-cycling PROM1+ cells (bottom bar). h Gene Ontology enrichment analysis of marker genes more expressed in cycling PROM1+ cells when compared to non-cycling cells (n = 313 non-cycling pediatric PROM1+ malignant cells; n = 523 cycling pediatric PROM1+ malignant cells) (one-sided Fisher’s exact test). i Gene Ontology enrichment analysis of marker genes more expressed in non-cycling PROM1+ cells when compared to PROM1- cells (n = 313 non-cycling pediatric PROM1+ malignant cells; n = 548 non-cycling pediatric PROM1- malignant cells) (one-sided Fisher’s exact test).",
  "figure_2": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) together with pPB-mProm1-mVenus-p27K− (Prom1-Venus-p27). Mice were sacrificed at humane endpoint. b Survival curve (p = 0.0001) of mice injected with only TPR-MET (n = 7 mice, black line) or both TPR-MET and p53R273C (n = 7 mice, blue line). c Mosaic images of brain sections showing Prom1-Venus-p27 expressing cells within the tumor (mCherry+) (n = 10 mice). d, e Images (d) and quantifications (e) of mVenus+ cells (green) not expressing Ki67 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (n = 4 mice, 4818 cells). Each dot represents a brain section. f, g Images (f) and quantifications (g) of mVenus+ cells (green) labeled with EdU (red) (n = 2 mice, 429 cells). Cells in the SVZ of P2 CD1 mice were electroporated with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) together with pPB-mProm1-mVenus-p27K− (Prom1-Venus-p27). Mice were injected with EdU at P44 and brains were dissected at P45. h, i Images (h) and quantifications (i) of mVenus+ cells (green) expressing SOX2 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (n = 3 mice, 1966 cells). j, k Images (j) and quantifications (k) of mVenus+ cells (green) expressing OLIG2 (red) in the core and edge/infiltrative regions of the mCherry+ tumors expressing Prom1-Venus-p27 (for core n = 4 mice, 3753 cells; for infiltrating edge n = 4 mice, 1104 cells). l Images of mVenus+ cells (green) co-expressing N-cadherin (gray) in the core or edge/infiltrative areas of the mCherry+ tumors (red) expressing Prom1-Venus-p27 (n = 6 mice). N-cadherin expression level is shown as multi-colored LUT fire. Asterisks refer to Venus-p27 expressing cells. Scale bars (c) 2 mm, (d, f, h, j, l) 100 μm, (l, ROI) 50 μm, (j, ROI) 40 μm. Data are presented as mean ± SEM. P values are calculated by unpaired two-tailed non-parametric Mann–Whitney test (k). Kaplan–Meier survival curve followed by Log-rank (Mantel–Cox) test was used for testing difference in the survival of mice (b). Source data are provided as a Source Data file.",
  "figure_3": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry together with pPB-CAG-LSL-mVenus and pPB-mProm1-CreERT2-p27K−. Mice were injected with DMSO or Temozolomide (TMZ) every day from P30 to P34 and then with Tamoxifen every two days from P35 to P41. Brains were dissected at P42 and P56. b Quantification of the tumor size shown as percentage of mCherry+ area over DAPI+ area in brain sections of DMSO- (n = 7 mice at P42; n = 3 mice at P56) and TMZ-treated (n = 7 mice at P42; n = 5 mice at P56). Each dot represents a brain section. c Quantification of mVenus+ infiltrating cells in the tumor of DMSO- (n = 7 mice at P42; n = 3 mice at P56) and TMZ-treated (n = 7 mice at P42; n = 5 mice at P56). Each dot represents a brain section. d, e Images (d) and quantifications (e) of mVenus+ cells (green) co-expressing Ki67 (gray) in the core or edge/infiltrative regions of the mCherry+ tumors (red) of DMSO- (n = 6 mice at P42, 576 cells for core and 380 cells for infiltrating edge; n = 3 mice at P56, 219 cells for core and 85 cells for infiltrating edge) and TMZ-treated (n = 7 mice at P42, 613 cells for core and 1058 cells for infiltrating edge; n = 5 mice at P56, 952 cells for core and 82 cells for infiltrating edge). Each dot represents a tumor area. f, g Images (f) and quantifications (g) of mVenus+ cells (green) co-expressing OLIG2 (gray) in the core or edge/infiltrative areas of the mCherry+ tumors (red) of DMSO- (n = 6 mice at P42, 736 cells for core and 447 cells for infiltrating edge; n = 3 mice at P56, 237 cells for core and 123 cells for infiltrating edge) and TMZ-treated (n = 7 mice at P42, 722 cells for core and 527 cells for infiltrating edge; n = 5 mice at P56, 1620 cells for core and 229 cells for infiltrating edge). Scale bars (d, f) 100 μm. Data are presented as mean ± SEM. p values calculated by Kruskal–Wallis test followed by Dunn’s test for multiple comparison (b, c, d). Source data are provided as a Source Data file.",
  "figure_4": "a Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-mProm1-mVenus-p27K− with or without pPB-mProm1-DTA-p27K−. b Images of brain sections showing Prom1-Venus-p27 expressing cells within the tumor (mCherry+) of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) pPB-mProm1-DTA-p27K− (Prom1-DTA-p27). c Survival curve of mice injected with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-mProm1-mVenus-p27K− without (n = 23 mice) or with pPB-mProm1-DTA-p27K− (n = 18 mice). d, e Quantifications of mVenus+ (green) (d) and mCherry+ (red) (e) area in the brain sections of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) Prom1-DTA-p27. Each dot represents a brain section and color code is applied to each mouse. f Quantification of the distance of the infiltrated mCherry+ cells from the tumor edge in the brain sections of mice co-electroporated without (n = 5 mice) or with (n = 5 mice) Prom1-DTA-p27. The furthest 3 cells for each section were considered; each dot represents a cell and color code is applied to each mouse. g Electroporation of cells in the SVZ of P2 CD1 mice with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry, pPB-mProm1-mVenus-p27K−, pPB-mProm1-CreERT2-p27K− and pPB-CAG-LSL-DTA. Mice were injected with Tamoxifen every two days from P17 to P45. h–j, Images (h) and quantifications of mVenus+ (green) (i) and mCherry+ (red) (j) area in the brain sections of mice un-injected (n = 4) or injected (n = 4 mice) with Tamoxifen (Tam). Each dot represents a brain section and color code is applied to each mouse. k Quantification of the distance of the infiltrated mCherry+ or mVenus+ cells from the tumor edge in the brain sections of mice un-injected (n = 4 mice) or injected (n = 4 mice) with Tamoxifen. The furthest 3 cells for each section were considered; each dot represents a cell and color code is applied to each mouse. Scale bars (b, h) 2 mm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed non-parametric Mann–Whitney test (d, e, f, i, k) or unpaired two-tailed Student’s t test (j). Kaplan–Meier survival curve followed by Log-rank (Mantel-Cox) test was used for testing difference in the survival of mice (b). Source data are provided as a Source Data file.",
  "figure_5": "a Scheme of the differentiation protocol of hiPSCs in forebrain organoids. At day 35 organoids were electroporated with pPB-CAG-mCherry (Cherry) or pPB-CAG-TPR-MET-ires-mCherry and pPB-CAG-p53R273C-ires-mCherry (TP-Cherry) and cultured for additional 30 days (30 dpe). b Images of electroporated organoids at 30 dpe (n = 7 organoids per type). c, d Images (c) and quantifications (d) of mCherry+ cells (red) co-expressing Ki67 (green) in organoids at 30 dpe electroporated with Cherry or TP-Cherry (n = 4 Cherry organoids, 368 cells; n = 6 TP-Cherry organoids, 1355 cells). Each dot represents an organoid section. e Electroporation of D35 organoids with pPB-CAG-TPR-MET-ires-mCherry, pPB-CAG-p53R273C-ires-mCherry and pPB-CAG-mVenus-p27K− (TP-cherry/Venus-p27). Organoids were fixed at 30 dpe. f, g Images (f) and quantifications (g) of mVenus+ cells (green) not expressing Ki67 (red) in TP-Cherry/Venus-p27 organoids at 30 dpe (n = 8 organoids, 298 cells). h Grafting of TP-Cherry/Venus-p27 organoids in the brains of nude mice at postnatal day 5 (P5). Brains were dissected at humane endpoint. i Image of TP-Cherry/Venus-p27 organoid-derived brain tumor (n = 4 mice). j, k Image (j) and quantifications (k) of mCherry+ (red) and mVenus+ (green) cells not expressing Ki67 (gray) at infiltrating edge of organoid-derived tumors (n = 3 mice, 340 cells). l Principal Component Analysis of the transcriptomes of TP-induced tumors (M1 and M2) in mouse, TP-organoids grafts (O1, O2, O3, O4) and published human adult low- and high-grade glioma samples (oligodendroglioma, Oligoastrocytoma, astrocytoma and glioblastoma) and pediatric high-grade glioma samples. m Grafting of TP-Cherry/Venus-p27 organoids co-expressing or not DTA-p27 in the brains of nude mice. Brains were dissected at P21. n Images of TP-Cherry/Venus-p27 (without or with DTA-p27) organoid-derived brain tumors (n = 3 mice per condition). o Quantification of the distance of the infiltrated mCherry+ cells from the tumor edge in the brain sections of mice grafted with TP-Cherry/Venus-p27 without (n = 3 mice) or with DTA-p27 (n = 3 mice). The furthest three cells for each section were considered; each dot represents a cell and color code is applied to each mouse. Scale bars (b) 600 μm, (c, f, j) 100 μm, (I, n) 2 mm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed Student’s t test (d, o). Source data are provided as a Source Data file.",
  "figure_6": "a TP-Cherry/Venus-p27 organoids at 30 dpe were treated with the listed drugs for 7 days. Organoids were live imaged at 0, 3 and 7 days of treatment. b Quantifications of mCherry+ and mVenus+ area and intensity at day 3 and day 7. Data were normalized to day 0. Each dot represents as single organoid (n = 11 organoids per condition). c Images of DMSO- or Harmine-treated organoids at day 0 and day 7 of treatment (n = 11 organoids per condition). d GB7 cells previously electroporated with pPB-CAG-mCherry (Cherry) and pPB-CAG-mVenus-p27K− (Venus-p27) were seeded one day prior treatment. Cells were treated with the listed drugs for 72 h and imaged every 24 h. Nuclei were counterstained with Hoechst for counting the number of nuclei. For each drug 3 wells were imaged, and experiments were conducted in duplicate. e Quantification of mVenus+/mCherry+ cells over the total of mCherry+ cells 24 h, 48 h and 72 h post treatment. Each dot represents a well (n = 6 wells per condition). Data were normalized on the DMSO-treated cells on the same day. f Images of DMSO- or Harmine-treated cells at 24 h, 48 h and 72 h post treatment (n = 54 images per condition). g GB7 cell-derived spheroids were embedded in collagen type I and live imaged at 0 h, 48 h and 72 h post embedding. Treatment with DMSO or Harmine started 2 days before embedding (Day 2 during spheroid formation). h, i Images (h) and quantifications (i) of spheroid invasion in the collagen matrix. Invasion was measured as increased area of mCherry+ cells from 0 h. Each dot represents a spheroid (n = 28 spheroids per condition). Data were normalized on the same spheroid at 0 h timepoint. Scale bars (c) 1 mm, (f) 400 μm, (h) 100 μm. Data are presented as mean ± SEM. P values were calculated by unpaired two-tailed non-parametric Mann–Whitney test or unpaired two-tailed Student’s t test (b, e, i) depending on whether data were normally distributed. Source data are provided as a Source Data file."
}